ESPR files Form 144 to sell 6,424 vested shares

ESPR filed a Form 144 reporting a proposed sale of 6,424 shares of Common Stock tied to restricted stock vesting on 03/16/2026.

Rhea-AI Filing Summary

ESPR filed a Form 144 reporting a proposed sale of 6,424 shares of Common Stock tied to restricted stock vesting on 03/16/2026. The filing also lists a prior sale of 7,337 shares on 12/17/2025 for 26906.25.

Insights

Securities Compliance Attorney

Form 144 shows an affiliate sale notice for 6,424 vested shares.

The filing lists 6,424 shares to be sold following restricted stock vesting dated 03/16/2026. Form 144 is a regulatory notice required when affiliates intend to sell resalable securities under Rule 144.

Timing and sale mechanics (broker, method) are not detailed in the excerpt; subsequent transaction reports will show execution and proceeds.

Corporate Filings Analyst

Previous sale activity is disclosed alongside the proposed sale.

The excerpt records a prior disposition of 7,337 shares on 12/17/2025 with proceeds of 26906.25. That prior sale is reported separately from the proposed 6,424 share sale.

Per the excerpt, cash‑flow treatment and exact distribution method for the proposed sale are not provided here; look for follow‑up reporting for execution details.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does ESPR's Form 144 report?

It reports a proposed sale of 6,424 common shares related to restricted stock vesting on 03/16/2026. The filing also discloses a prior sale of 7,337 shares on 12/17/2025.

Who is the selling party in the ESPR Form 144?

The excerpt lists Fidelity Brokerage Services LLC as the brokerage and shows an individual address for Benjamin Halladay. The filing names the affiliate and broker; exact beneficial owner attribution follows the form's header entries.

How much cash was reported from recent ESPR share sales?

The excerpt reports proceeds of 26906.25 from a prior sale of 7,337 shares on 12/17/2025. No proceeds are shown for the proposed 6,424 share sale in this excerpt.

Does the Form 144 indicate how the proposed ESPR shares will be sold?

The excerpt labels the shares as resulting from restricted stock vesting but does not specify sale method (block trade, open‑market, or broker‑dealers). Execution details are not included here.

Will this Form 144 change ESPR's outstanding share count?

This notice reports an intent to sell 6,424 vested shares; it does not state any change to total shares outstanding. Outstanding share figures are not provided in the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/17/2026 - 03:19 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001953943
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Esperion Therapeutics, Inc.
SEC File Number	001-35986
Address of Issuer	3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MICHIGAN 48108
Phone	734-887-3903
Name of Person for Whose Account the Securities are To Be Sold	Halladay Benjamin
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	6424	17374.98	256810482	03/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/16/2026	Restricted Stock Vesting	Issuer			6424	03/16/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Benjamin Halladay 3891 Ranchero Drive Suite 150 Ann Arbor MI 48108	Common	12/17/2025	7337	26906.25

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	03/17/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Joshua Schmitt, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Benjamin Halladay.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)